Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 19, 2016
Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glandsK Hirvonen, L Bäck, C Haglund, et al.
International Journal of Cancer|July 16, 2013
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateM J Duffy, R Lamerz, C Haglund, et al.
British Journal of Cancer|September 1, 1996
Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancerM Carpelan-Holmström, C Haglund, J Lundin, et al.
Gut|February 16, 2005
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer RegistryM Carpelan-Holmström, S Nordling, E Pukkala, et al.
Climacteric : the Journal of the International Menopause Society|November 13, 2008
Expression of the androgen receptor and syndecan-1 in breast tissue during different hormonal treatments in cynomolgus monkeysM Hofling, L Ma, L Sahlin, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|March 2, 2016
The Use of Blood Products in Adult Patients with BurnsV Koljonen, J Tuimala, C Haglund, et al.
International Journal of Cancer|March 10, 2001
Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancerJ P Wiksten, J Lundin, S Nordling, et al.
Anticancer Research|May 1, 2001
A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancerM Lundin, S Nordling, M Carpelan-Holmstrom, et al.
British Journal of Cancer|September 8, 2011
Prognostic role of CIP2A expression in serous ovarian cancerC Böckelman, H Lassus, A Hemmes, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2001
Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosisK Salmenkivi, J Arola, R Voutilainen, et al.
Pageof 11